23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Under the new Massachusetts Paid Family Leave Law, M.G.L c. 175M (“MAPFML”), employees and other c...
Read More >
Synopsis: A recent 4th Circuit decision reiterates the importance of aligning a plan fiduciary’s a...
Read More >
On April 6, 2018, the U.S. Department of Labor (DOL) issued Field Assistance Bulletin No. 2018-3 in ...
Read More >
On June 30, the Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ) re...
Read More >
In the coming months, be on the lookout for an increase in mergers and acquisitions financed by sell...
Read More >
In Burnett v. Pagliacci Pizza, Inc., 442 P.3d 1267 (Wash. Ct. App. 2019), the Washington Court of Ap...
Read More >